Anti-Human GOLM1/GP73 Antibody (SAA0106), PE

Catalog No.

FHJ23812

Species reactivity

Human

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Conjugation

PE

Applications

FCM

Target

Golgi phosphoprotein 2, C9orf155, Golgi membrane protein GP73, Golgi membrane protein 1, GOLPH2, GOLM1

Concentration

0.5 mg/ml

Endotoxin level

Please contact with the lab for this information.

Accession

Q8NBJ4

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300.

Stability and Storage

Store at 4°C for 12 months. Protect from light. Do not freeze.

Clone ID

SAA0106

Note

For research use only.

Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma., PMID:17662025

GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics., PMID:18781151

Quantitative analysis of elevated serum Golgi protein-73 expression in patients with liver diseases., PMID:19008260

[Correlaion between serum Golph2 protein and hepatocellular carcinoma]., PMID:19403029

Up-regulated Golgi phosphoprotein 2 (GOLPH2) expression in lung adenocarcinoma tissue., PMID:20501332

[Generation of monoclonal antibody to GP73 based on antigen epitope]., PMID:20619090

A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma., PMID:21231906

Value of Golgi protein 73 monoclonal antibody in diagnosis of hepatocellular carcinoma., PMID:21375936

Golgi protein 73(GP73), a useful serum marker in liver diseases., PMID:21663469

Monoclonal antibody preparation of Golgi phosphoprotein 2 and preliminary application in the early diagnosis of hepatocellular carcinoma., PMID:23727927

[Retrospective observation of dynamic levels of serum Golgi protein 73 in patients prior to the onset of liver cancer]., PMID:24246080

[Cloning and expressing of golgi protein73 gene fragment and preparation of monoclonal antibodies against the recombinant protein]., PMID:24579482

[Establishment of a quantitative detection method for Golgi protein73]., PMID:24645330

[Preparation of anti-Golgi protein 73 polyclonal antibodies and establishment of particle-enhanced turbidimetric immunoassay for Golgi protein 73]., PMID:25652870

Evaluation of a magnetic particles-based chemiluminescence enzyme immunoassay for Golgi protein 73 in human serum., PMID:25801213

mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice., PMID:25980751

Manganese modified CdTe/CdS quantum dots as an immunoassay biosensor for the detection of Golgi protein-73., PMID:26340559

Multiple lectin assays for detecting glyco-alteration of serum GP73 in liver diseases., PMID:26342810

Screening and Identification of ssDNA Aptamer for Human GP73., PMID:26583119

Identification and characterization of monoclonal antibodies against GP73 for use as a potential biomarker in liver cancer screening and diagnosis., PMID:27088654

Detection of Hepatocellular Carcinoma Biomarker Golgi Protein 73 Based on Magnetic Enzyme-Linked Immunoassay., PMID:29620331

A sensitive three monoclonal antibodies based automatic latex particle-enhanced turbidimetric immunoassay for Golgi protein 73 detection., PMID:28054632

PDGFA/PDGFRα-regulated GOLM1 promotes human glioma progression through activation of AKT., PMID:29282077

Development of an alpha-fetoprotein and Golgi protein 73 multiplex detection assay using xMAP technology., PMID:29630871

Highly sensitive electrochemical immunosensor for golgi protein 73 based on proximity ligation assay and enzyme-powered recycling amplification., PMID:30327105

GOLM1 Stimulation of Glutamine Metabolism Promotes Osteoporosis via Inhibiting Osteogenic Differentiation of BMSCs., PMID:30396165

Serum Golgi protein 73 is a marker comparable to APRI for diagnosing significant fibrosis in children with liver disease., PMID:30425268

Magnetic Nanoparticle-Based Automatic Chemiluminescent Enzyme Immunoassay for Golgi Protein 73 and the Clinical Assessment., PMID:30486937

Ratiometric Immunosensor for GP73 Detection Based on the Ratios of Electrochemiluminescence and Electrochemical Signal Using DNA Tetrahedral Nanostructure as the Carrier of Stable Reference Signal., PMID:30742421

Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis., PMID:31081083

[Development of a quantitative serum assay of Golgi protein 73 in hepatocellular carcinoma using xMAP technology]., PMID:31137168

Therapeutic Targeting of Golgi Phosphoprotein 2 (GOLPH2) with Armed Antibodies: A Preclinical Study of Anti-GOLPH2 Antibody Drug Conjugates in Lung and Colorectal Cancer Models of Patient Derived Xenografts (PDX)., PMID:31541350

Metal exposure from additive manufacturing and its effect on the nasal lavage fluid proteome - a pilot study., PMID:34464420

Suppression of GOLM1 by EGCG through HGF/HGFR/AKT/GSK-3β/β-catenin/c-Myc signaling pathway inhibits cell migration of MDA-MB-231., PMID:34536514

GP73 is a glucogenic hormone contributing to SARS-CoV-2-induced hyperglycemia., PMID:34992299

GOLM1 Promotes Atherogenesis by Activating Macrophage EGFR-ERK Signaling Cascade., PMID:40026146

Document Download

Anti-Human GOLM1/GP73 Antibody (SAA0106), PE.pdf